Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment.

作者: Monica Butnariu , Zeeshan Javed , Javad Sharifi-Rad , Shahid Raza , Muhammad Javed Iqbal

DOI: 10.1186/S12935-021-01888-X

关键词:

摘要: Cancer is a complex disease orchestrated by various extrinsic and intrinsic pathways. In recent years, there has been keen interest towards the development of natural extracts-based cancer therapeutics with minimum adverse effects. pursuit effective strategy, wide variety products-derived compounds have addressed for their anticancer Apigenin naturally-occurring flavonoid present abundantly in fruits vegetables. Decades research delineated pharmacological biological properties apigenin. Specifically, apigenin-mediated activities documented types cancer, but generalized scientific evidence encompassing molecular interactions processes, such as regulation apoptotic machinery, aberrant cell signaling oncogenic protein network not comprehensively covered. this sense, review we attempted to focus on pathways cancers. We also cutting-edge which unveiled remarkable abilities apigenin interact microRNAs modulate key cellular special emphasis nano-formulations that can help targeted delivery be therapeutic solution treatment

参考文章(108)
Shile Huang, Inhibition of PI3K/Akt/mTOR signaling by natural products Anti-cancer Agents in Medicinal Chemistry. ,vol. 13, pp. 967- 970 ,(2013) , 10.2174/1871520611313070001
Indra Rajendran, Harini Dhandapani, Rajaram Anantanarayanan, Rama Rajaram, Apigenin mediated gold nanoparticle synthesis and their anti-cancer effect on human epidermoid carcinoma (A431) cells RSC Advances. ,vol. 5, pp. 51055- 51066 ,(2015) , 10.1039/C5RA04303D
Martin R Sprick, Eva Rieser, Heiko Stahl, Anne Grosse-Wilde, Markus A Weigand, Henning Walczak, Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8 The EMBO Journal. ,vol. 21, pp. 4520- 4530 ,(2002) , 10.1093/EMBOJ/CDF441
Chiara Dianzani, Gian Paolo Zara, Giovanni Maina, Piergiorgio Pettazzoni, Stefania Pizzimenti, Federica Rossi, Casimiro Luca Gigliotti, Eric Stefano Ciamporcero, Martina Daga, Giuseppina Barrera, Drug delivery nanoparticles in skin cancers BioMed Research International. ,vol. 2014, pp. 895986- 895986 ,(2014) , 10.1155/2014/895986
Hyo-Seok Seo, Mohamed Asaduzzaman Sikder, Hyun Jae Lee, Jiho Ryu, Choong Jae Lee, Apigenin Inhibits Tumor Necrosis Factor-α-Induced Production and Gene Expression of Mucin through Regulating Nuclear Factor-Kappa B Signaling Pathway in Airway Epithelial Cells Biomolecules & Therapeutics. ,vol. 22, pp. 525- 531 ,(2014) , 10.4062/BIOMOLTHER.2014.094
Sreemanti Das, Jayeeta Das, Asmita Samadder, Avijit Paul, Anisur Rahman Khuda-Bukhsh, Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro Toxicology Letters. ,vol. 223, pp. 124- 138 ,(2013) , 10.1016/J.TOXLET.2013.09.012
Mrinmay Chakrabarti, Naren L. Banik, Swapan K. Ray, miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo Experimental Cell Research. ,vol. 319, pp. 1575- 1585 ,(2013) , 10.1016/J.YEXCR.2013.02.025
David A. Foster, Suman Mukhopadhyay, Mahesh Saqcena, Amrita Chatterjee, Avalon Garcia, Maria A. Frias, Reciprocal Regulation of AMP-activated Protein Kinase and Phospholipase D Journal of Biological Chemistry. ,vol. 290, pp. 6986- 6993 ,(2015) , 10.1074/JBC.M114.622571
Xin Tong, Jill Pelling, Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention. Anti-cancer Agents in Medicinal Chemistry. ,vol. 13, pp. 971- 978 ,(2013) , 10.2174/18715206113139990119
R R Ruela-de-Sousa, G M Fuhler, N Blom, C V Ferreira, H Aoyama, M P Peppelenbosch, Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy Cell Death and Disease. ,vol. 1, ,(2010) , 10.1038/CDDIS.2009.18